share_log

UnitedHealth | 8-K: Signing of Underwriting and Pricing Agreements

UnitedHealth | 8-K: Current report

聯合健康 | 8-K:重大事件
SEC announcement ·  03/21 16:37
Moomoo AI 已提取核心訊息
On March 19, 2024, UnitedHealth Group Incorporated, a healthcare and insurance giant, entered into agreements to sell a series of notes with varying interest rates and maturities, totaling $5.5 billion. The notes, ranging from 4.600% to 5.500% in interest rates and with maturity dates spanning from 2027 to 2064, were sold under an Underwriting Agreement and a Pricing Agreement with major financial institutions including BofA Securities, Barclays Capital, J.P. Morgan Securities, and Mizuho Securities USA. The sale was completed on March 21, 2024, with the issuance of the notes under an existing Indenture with U.S. Bank Trust Company as trustee. The transaction was registered under the Securities Act of 1933 and incorporated into UnitedHealth's automatic shelf registration statement. The company filed the necessary documents with the SEC, including the Underwriting and Pricing Agreements, Officers' Certificates, Company Orders, and legal opinion regarding the validity of the notes.
On March 19, 2024, UnitedHealth Group Incorporated, a healthcare and insurance giant, entered into agreements to sell a series of notes with varying interest rates and maturities, totaling $5.5 billion. The notes, ranging from 4.600% to 5.500% in interest rates and with maturity dates spanning from 2027 to 2064, were sold under an Underwriting Agreement and a Pricing Agreement with major financial institutions including BofA Securities, Barclays Capital, J.P. Morgan Securities, and Mizuho Securities USA. The sale was completed on March 21, 2024, with the issuance of the notes under an existing Indenture with U.S. Bank Trust Company as trustee. The transaction was registered under the Securities Act of 1933 and incorporated into UnitedHealth's automatic shelf registration statement. The company filed the necessary documents with the SEC, including the Underwriting and Pricing Agreements, Officers' Certificates, Company Orders, and legal opinion regarding the validity of the notes.
2024年3月19日,醫療保健和保險巨頭UnitedHealth Group Incorporated達成協議,出售一系列利率和到期日各不相同的票據,總額爲55億美元。這些票據的利率從4.600%到5.500%不等,到期日爲2027年至2064年,是根據承保協議和與美國美銀證券、巴克萊資本、摩根大通證券和美國瑞穗證券等主要金融機構簽訂的定價協議出售的。此次出售於2024年3月21日完成,根據現有契約發行了票據,由美國銀行信託公司擔任受託人。該交易是根據1933年《證券法》註冊的,並已納入UnitedHealth的自動上架註冊聲明。該公司向美國證券交易委員會提交了必要的文件,包括承保和定價協議、高管證書、公司命令以及有關票據有效性的法律意見。
2024年3月19日,醫療保健和保險巨頭UnitedHealth Group Incorporated達成協議,出售一系列利率和到期日各不相同的票據,總額爲55億美元。這些票據的利率從4.600%到5.500%不等,到期日爲2027年至2064年,是根據承保協議和與美國美銀證券、巴克萊資本、摩根大通證券和美國瑞穗證券等主要金融機構簽訂的定價協議出售的。此次出售於2024年3月21日完成,根據現有契約發行了票據,由美國銀行信託公司擔任受託人。該交易是根據1933年《證券法》註冊的,並已納入UnitedHealth的自動上架註冊聲明。該公司向美國證券交易委員會提交了必要的文件,包括承保和定價協議、高管證書、公司命令以及有關票據有效性的法律意見。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息